Sweden Promotes Women's Health with Menopause Awareness Event and Rising Testosterone Therapy Use
Sweden advances women's health through a Rosa Bandet menopause awareness event and increasing testosterone therapy use among pre-menopausal women, reflecting growing dialogue and medical trends.
Key details
- Ownit organized a successful Rosa Bandet fitness event to promote menopause awareness and raised about 6,000 kronor.
- The event emphasized the importance of discussing menopause and increasing support for women's well-being.
- Testosterone therapy use among Swedish women aged 40 to 59 is increasing, with over 5,000 users.
- Medical experts note mixed results from testosterone treatment and ongoing concerns regarding side effects.
In Sweden, recent initiatives and medical trends are highlighting women’s health, particularly focusing on menopause awareness and hormone therapy among pre-menopausal women.
A notable event organized by the Mölnlycke-based company Ownit brought together women for a fitness-themed evening in support of the Rosa Bandet campaign. The gym session, accentuated with pink and white balloons, fostered a lively community atmosphere involving mothers, daughters, and friends. Therese Ekblad, one of the event’s founders, expressed satisfaction with the turnout and emphasized the growing dialogue around menopause. She stressed the importance of informing women that they do not have to suffer unnecessarily during this life phase and highlighted the need for more research on women-related diseases. The event successfully raised about 6,000 kronor from participant fees and additional sales of Rosa Bandet products, all earmarked for vital women's health research.
Meanwhile, medical discussions reveal an increasing trend in testosterone therapy among Swedish pre-menopausal women. Over 5,000 women aged 40 to 59 are now using testosterone treatments to potentially boost sexual desire, energy, and motivation. Research confirms that testosterone can enhance these aspects, although the effects vary. Some women experience significant improvements, while others notice little benefit. A leading gynecologist commented that the therapy’s impact is “a bit fifty-fifty,” with half of the patients seeing good effects. Due to concerns about side effects, some doctors remain cautious and choose not to prescribe testosterone, prioritizing patient safety.
Together, these developments underline a growing awareness and proactive approach towards women’s health in Sweden, highlighting both community engagement and evolving medical practices.